Cabaletta Bio (CABA)
(Delayed Data from NSDQ)
$4.26 USD
-0.28 (-6.17%)
Updated Sep 6, 2024 03:59 PM ET
After-Market: $4.25 -0.01 (-0.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Cabaletta Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -67.68 | -52.98 | -46.29 | -33.34 | -16.94 |
Depreciation/Amortization & Depletion | 0.61 | 1.64 | 0.80 | 0.47 | 0.10 |
Net Change from Assets/Liabilities | 0.10 | -4.09 | 5.64 | 1.91 | -1.51 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.41 | 9.05 | 5.75 | 4.19 | 2.30 |
Net Cash From Operating Activities | -53.55 | -46.38 | -34.11 | -26.77 | -16.05 |
Property & Equipment | -0.69 | -2.45 | -1.17 | -0.64 | -0.69 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -21.76 | -24.76 | 7.17 | -7.35 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -22.45 | -27.22 | 6.00 | -7.98 | -0.69 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 187.63 | 32.98 | 48.90 | -0.02 | 121.22 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -1.29 |
Net Cash from Financing Activities | 187.63 | 32.98 | 48.90 | -0.02 | 119.93 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 111.63 | -40.62 | 20.79 | -34.78 | 103.19 |
Cash at Beginning of Period | 81.61 | 122.22 | 101.43 | 136.20 | 33.02 |
Cash at End of Period | 193.24 | 81.61 | 122.22 | 101.43 | 136.20 |
Diluted Net EPS | -1.65 | -1.81 | -1.80 | -1.44 | -4.07 |
Fiscal Year End for Cabaletta Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -52.65 | -25.05 | -67.68 | -46.79 | -30.34 |
Depreciation/Amortization & Depletion | 0.04 | -0.03 | 0.61 | 0.54 | 0.75 |
Net Change from Assets/Liabilities | -4.16 | -4.13 | 0.10 | -0.55 | -1.10 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 11.99 | 5.22 | 13.41 | 9.70 | 6.20 |
Net Cash From Operating Activities | -44.78 | -23.99 | -53.55 | -37.10 | -24.50 |
Property & Equipment | -1.58 | -0.81 | -0.69 | -0.50 | -0.44 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 24.50 | 0.00 | -21.76 | -23.09 | -23.09 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 22.92 | -0.81 | -22.45 | -23.59 | -23.52 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.23 | 6.86 | 187.63 | 94.58 | 94.48 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.23 | 6.86 | 187.63 | 94.58 | 94.48 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -14.63 | -17.95 | 111.63 | 33.89 | 46.47 |
Cash at Beginning of Period | 193.24 | 193.24 | 81.61 | 81.61 | 81.61 |
Cash at End of Period | 178.61 | 175.29 | 193.24 | 115.50 | 128.07 |
Diluted Net EPS | -0.56 | -0.51 | -0.47 | -0.36 | -0.37 |